Market closed
Lexeo Therapeutics, Inc./$LXEO
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Lexeo Therapeutics, Inc.
Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.
Ticker
$LXEO
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
72
ISIN
US52886X1072
Website
LXEO Metrics
BasicAdvanced
$100M
-
-$3.09
-
-
Price and volume
Market cap
$100M
52-week high
$5.55
52-week low
$1.45
Average daily volume
1.1M
Financial strength
Current ratio
5.52
Quick ratio
5.319
Long term debt to equity
6.208
Total debt to equity
8.494
Interest coverage (TTM)
-772.01%
Management effectiveness
Return on assets (TTM)
-46.11%
Return on equity (TTM)
-85.37%
Valuation
Price to book
0.85
Price to tangible book (TTM)
0.85
Price to free cash flow (TTM)
-1.168
Growth
Earnings per share change (TTM)
-75.05%
3-year earnings per share growth (CAGR)
-54.39%
LXEO News
AllArticlesVideos
Lexeo: Alignment Gained With FDA Brings Further LX2006 Program Advancement
Seeking Alpha·5 days ago
Lexeo Therapeutics to Present New CMC Data at the 28th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
GlobeNewsWire·1 week ago
Gene Therapy For Fatal Rare Disease-Associated Heart Condition - Lexeo Therapeutics Candidate Shows Improvements In Trials
Benzinga·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Lexeo Therapeutics, Inc. stock?
Lexeo Therapeutics, Inc. (LXEO) has a market cap of $100M as of May 10, 2025.
What is the P/E ratio for Lexeo Therapeutics, Inc. stock?
The price to earnings (P/E) ratio for Lexeo Therapeutics, Inc. (LXEO) stock is 0 as of May 10, 2025.
Does Lexeo Therapeutics, Inc. stock pay dividends?
No, Lexeo Therapeutics, Inc. (LXEO) stock does not pay dividends to its shareholders as of May 10, 2025.
When is the next Lexeo Therapeutics, Inc. dividend payment date?
Lexeo Therapeutics, Inc. (LXEO) stock does not pay dividends to its shareholders.
What is the beta indicator for Lexeo Therapeutics, Inc.?
Lexeo Therapeutics, Inc. (LXEO) does not currently have a Beta indicator.